Wednesday 21 February 2018

Intrapartum monitoring devices market expected to reach USD 2.83 billion by 2025 : Grand View Research, Inc.


The global intrapartummonitoring devices market is expected to reach USD 2.83 billion by 2025, according to a new report by Grand View Research, Inc. The rising occurrences of preterm birth are resulting in increased infant mortality. The mortality rates differ across the globe, owing to the disparities of income, and lack of access to appropriate maternal care facilities in different regions. The regions with larger lower income groups face the highest infant mortality rates due to inadequate availability of obstetric monitoring and other infant care facilities. Effective maternal and postnatal care can help save more than 3 quarters of the premature babies.
According to the reports of WHO, annually 15.0 million infants are born premature. This number has been observed to be on a rise in the past few years. There are multiple causes for premature deliveries, such as high blood pressure, chronic conditions, infections, multiple pregnancies, early induction of labor. Hence, propelling the need for obstetric devices across the globe.
Rising awareness regarding availability of screening and monitoring procedures, growing prevalence of obesity & Gestational   Diabetes Mellitus (GDM) and increasing demand for improved intrapartum devices are expected to propel the market over the forecast period. 

Full research report on intrapartum monitoring devices market analysis: https://www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market

Further key findings from the study suggest:
·         The growing prevalence of obesity, rising preterm birth rate and increasing need for critical obstetric care is primarily driving the market growth
·         The electrodes dominated the market, owing to their affordability, higher adoption volume and repeat purchase.
·         The monitors segment is expected to exhibit fastest growth over the forecast period owing to the technological advancements.
·         North America dominated the market in 2016, owing to rising prevalence of obesity and diabetes, various government initiatives creating awareness regarding rising incidences of preterm births, availability of monitoring test options, and highly developed healthcare infrastructure.
·         Constant rise in the cases of preterm births and infant mortality rates are observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
·         The key players of the market include Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, and Olympus Corporation.
·         These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the intrapartum monitoring devices market report on the basis of device type and region:
Device Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Monitors
·         Electrodes
o    Fetal Scalp Electrodes
o    Intrauterine Pressure Catheter
o    Transducer for FHR
o    Transducer for Uterine Contractions
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


Tuesday 20 February 2018

Agrochemicals market expected to reach USD 308.92 billion by 2025 : Grand View Research, Inc.


The global agrochemicals market is expected to reach USD 308.92 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for crop protection chemicals, such as fungicides, herbicides, and insecticides, is expected to be the biggest driver of the agrochemicals industry over the forecast period.  
Shrinking arable land due to rapid industrialization and population explosion has resulted in increased use of agrochemicals, such as fertilizers and plant growth regulators, further triggering the market growth. The growing demand for crops as animal fodder and fiber in the textile industry has also provided the necessary boost to the agrochemicals industry.
Fertilizers dominated the agrochemicals market in 2016. Nitrogenous and phosphate fertilizers were most widely used due to their easy availability and low prices. However, the new trend of organic farming, which involves complete elimination of chemical-based fertilizers, has increased the demand for biofertilizers.
The demand for agrochemicals is expected to be the highest in Asia Pacific. The region is known for its agro-based countries such as India, Sri Lanka, and China, which are majorly dependent on agriculture and related industries for economic growth.
Full research report on agrochemicals market analysis: http://www.grandviewresearch.com/industry-analysis/agrochemicals-market

Further key findings from the report suggest:
·         The global agrochemicals market, in terms of value, was USD 215.18 billion in 2016 and is projected to reach USD 308.92 billion by 2025, growing at a CAGR of 4.1% from 2017 to 2025
·         Fertilizers, which accounted for 58.8% of the market in 2016, in terms of revenue, are expected to witness growth on account of increasing pressure on agricultural land to increase yield in a short time span
·         Crop protection chemicals, in terms of revenue, are expected to grow at a CAGR of 5.5% from 2017 to 2025 due to rising occurrences of pest and rodent attacks damaging crops
·         The market for agrochemicals in cereals & grains was valued at USD 80.01 billion in 2016. The application segment is expected to grow owing to an increase in the demand for whole grain products.
·         Oilseeds & pulses, which are considered to have high protein content, are projected to grow at the highest CAGR of 4.9%, in terms of value, from 2017 to 2025
·         The market in Asia Pacific is expected to witness the highest growth over the forecast period due to the growing agro-based industries including sugar, textiles, vegetable oil manufacturing, and animal husbandry
·         Bayer CropScience, Agrium, and Yara International were some of the key manufacturers in 2016 with distribution facilities spread across all regions
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers
Grand View Research has segmented the global agrochemicals market on the basis of product, application, and region:
Agrochemicals Product Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         Fertilizers
·         Crop Protection Chemicals
·         Plant Growth Regulators
·         Others
Agrochemicals Application Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         Cereals & Grains
·         Oilseeds & Pulses
·         Fruits & Vegetables
·         Others
Agrochemicals Regional Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)
·         North America
o    U.S.
·         Europe
o    Germany
o    Spain
·         Asia Pacific
o    China
o    India
·         Central & South America
o    Brazil
·         Middle East & Africa 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


Antipsychotic drugs market expected to reach USD 14.4 billion by 2025 : Grand View Research, Inc.


The global antipsychotic drugs market is expected to reach USD 14.4 billion by 2025, according to a new report by Grand View Research, Inc. The continuous development of better next-generation products to overcome adverse effects and unwanted reactions of existing products is creating demand for newer products. This factor is anticipated to propel the market.
Rapid growth of antipsychotics can be attributed to the rising prevalence of psychosis and other mental disorders. Governments are focused on creating awareness regarding mental health and psychological illnesses, which is further anticipated to drive the demand for antipsychotics. Government bodies in collaboration with major players conduct social programs to break the stigma related to psychotic disorders that exists in the society.
Adverse effects of antipsychotics, such as insomnia, dry mouth, drowsiness, and blurred vision, are expected to affect the growth by decreasing the level of acceptance in patients. In addition, the possibility of dependency, habit formation, or addiction is affecting the adoption of these drugs.
Established brands such as, Zyprexa lost patent protection in October 2011, followed by Seroquel and Risperdal in 2012, which hampers the market growth for these drugs. Also, the entry of generic versions of these products slowed the growth of the already existing brands.
Full research report on antipsychotic drugs market analysis: http://www.grandviewresearch.com/industry-analysis/antipsychotic-drugs-market

Further Key Findings From the Study Suggest:
·         The growing prevalence of mental disorders, increased investments on R&D, and rising awareness regarding these conditions are augmenting the growth of the market.
·         The first-generation of antipsychotics have serious adverse effects and are very rarely used, hence they hold negligible share in the market.
·         The second-generation segment of drugs accounted for the largest share in 2015 and are anticipated to further expand during the forecast period despite the adverse effects
·         As of January 2016, the third-generation segment has only one approved product, Abilify. It has negligible adverse effects and is expected to be the fastest growing segment over the forecast period
·         In 2015, North America dominated the global space with the largest revenue share owing to rising prevalence of mental illnesses
·         Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding mental disorders and improving access to treatment
·         Some of the major players in this market are Johnson & Johnson; Pfizer, Inc.; Eli Lilly & Co.; and Bristol-Myers Squibb

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the antipsychotic drugs market by drug class, application, and region:
Antipsychotics Drug Class Outlook (Revenue, USD Million; 2014 - 2025)
·         First Generation
·         Second Generation
·         Third Generation
Antipsychotics Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Schizophrenia
·         Bipolar disorder
·         Unipolar depression
·         Dementia
·         Others
Antipsychotics Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com

Newborn screening market Expected to reach USD 1.43 billion by 2022 : Grand View Research Inc.


The global newborn screening market is expected to reach USD 1.43 billion by 2022, according to a new report by Grand View Research Inc. Increasing occurrence of congenital disorders that lead to mental retardation or dysfunctioning body organs and the availability of advanced screening technologies are expected to drive market growth over the forecast period.
Furthermore, the market is expected to witness a boost in demand owing to, the presence of Federal Bodies involved in organizing awareness and quality assurance programs to imbibe faith and decrease the number of deaths caused due to negligence & non-screening. For instance, in 2011, the Ministry of Health, Japan recommended the use of mass spectrometry in newborn screening and by 2014, the entire nation started utilizing it for 19 critical conditions.
Full research report on newborn screening market analysis: http://www.grandviewresearch.com/industry-analysis/newborn-screening-market

Further key findings from the report suggest:
·         Tandem mass spectroscopy is expected to account for over 25% of newborn screening market share by 2022, owing to its ability to render faster diagnosis and cost effectiveness.
·         Pulse oximetry is expected to witness gains of over 9.0% over the forecast period. Masimo’s Eve software and Radical-7 oximeter gained CE marking in 2014 leading to a growth in demand supported by quality assurance and better analysis.
·         Dry blood spot test is expected to witness lucrative growth over the forecast period. Free distribution of filter paper by government is expected to boost the primary screening of all newborns, thereby, accelerating market growth.
·         Presently, 100% screening of over 4 million neonates is carried out in the North America annually. Encouraging efforts to prevent long term disabilities by healthcare providers and government agencies are some vital factors influencing regional market growth. Presence of favorable reimbursement policies reduces the burden of treatment cost, thereby, promoting higher procedure volumes
·         Asia Pacific newborn screening market is expected to witness the fastest growth of over 11.0% during the forecast period. This growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure levels, increasing disease prevalence rate, and the introduction of supportive government initiatives.
·         Some key players of this market include Agilent Technologies Inc., AB Sciex LLC, Natus Medical Inc., PerkinElmer Inc., Covidien Plc, Masimo Corp., Trivitron Healthcare, Bio-Rad Laboratories Inc. GE Healthcare and Waters Corp.
·         Market participants are constantly engaged in developing technologically advanced products in an attempt to improve presence and ensure sustainability. PerkinElmer’s “EnLite Neonatal TREC Kit” gained FDA approval in 2014 for the diagnosis and treatment of Severe Combined Immunodeficiency Disease (SCID) leading to replacement of non-approved tests in certain states of the U.S.
·         Over 20 states along with the Navajo Nation and the District of Columbia have put screening programs into practice for the same.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the global newborn screening market on the basis of product, technology, test type and region:
Product Outlook (Revenue, USD Million, 2012 - 2022)
·         Instruments
·         Reagents & Assay Kits
Technology Outlook (Revenue, USD Million, 2012 - 2022)
·         Tandem Mass Spectrometry
·         Pulse Oximetry
·         Enzyme Based Assays
·         DNA Assays
·         Electrophoresis
Test Outlook (Revenue, USD Million, 2012 - 2022)
·         Dry Blood Spot Test
·         Critical Congenital Heart Disease (CCHD)
·         Hearing Screen
Regional Outlook (Revenue, USD Million, 2012 - 2022) 
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
o    France
o    Rest of Europe
·         Asia Pacific
o    Japan
o    China
o    India
o    Rest of Asia Pacific
·         Latin America
o    Brazil
o    Mexico
o    Rest of Latin America
·         Middle East and Africa (MEA)
o    South Africa  
o    Rest of Middle East and Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com